Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Le Phong, President and CEO of Strategy Inc (NASDAQ:MSTR), executed a sale of 83,738 Class A Common Stock shares on June 5, 2026, netting approximately $11.1 million. The divestment followed the vesting of 190,740 performance stock units on June 3, 2026. Proceeds are designated for tax withholding on the equity awards. The transaction occurred with…
Andrew Kang, Executive Vice President and Chief Financial Officer at Strategy Inc. (NASDAQ:MSTR), executed a $3.9 million sale of 33,662 Class A Common Stock shares on June 5, 2026. The transaction, facilitated through a Rule 10b5-1 plan established in May 2024, was designed to meet tax withholding requirements triggered by the vesting of performan…
David Scott Offer, Executive Vice President and General Counsel at Flex Ltd., recently completed a series of stock sales totaling approximately $5.08 million. The transactions involved 33,000 ordinary shares sold on June 5, 2026, through a trust holding. These sales were executed under a Rule 10b5-1(c) trading plan established in February 2026, pro…
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) President and CEO George Kurtz sold 1,220 shares of Class A common stock on June 4, 2026, realizing proceeds of $868,977. The transactions were executed under a Rule 10b-5 plan established in January 2026. Following the sale, Kurtz retains direct ownership of 2,137,022 shares, including those tied to vestin…
TD Cowen continues to expect the U.S. Securities and Exchange Commission to grant exemptive relief that would allow trading in tokenized equities within months. The pace of the process has been slower than many anticipated, driven primarily by political considerations in Washington and the need to finalize practical regulatory and operational detai…
CrowdStrike Holdings, Inc. President and CEO George Kurtz has completed the sale of 3,680 Class A common stock shares across multiple transactions on June 3 and June 4, 2026. The transactions, executed under a Rule 10b5-1 plan established on January 6, 2026, resulted in proceeds totaling $2,760,328. The sale occurred while CrowdStrike shares were t…
Personalis Inc. (NASDAQ: PSNL) has seen significant executive activity and strategic milestones. CFO and COO Aaron Tachibana executed a stock sale under a pre-arranged plan, while the company reported substantial growth in its NeXT Personal minimal residual disease test and expanded Medicare coverage for the diagnostic. These developments occur aga…
Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc. (NASDAQ:HNGE), executed a series of transactions resulting in the sale of 50,000 Class A Common Stock shares on June 5, 2026, totaling $3,276,843. The sales occurred within a pre-established Rule 10b5-1 trading plan adopted in December 2025, with shares transacting be…
Andrew John Partridge, Chief Growth Officer at Grail, Inc., executed a transaction involving the sale of 1,491 shares of the company's common stock on June 4, 2026. The transaction, valued at $91,070, was conducted at a weighted average price of $61.08 per share. This disposition is categorized as an automatic sell-to-cover mechanism, typically uti…
Global Graphene Group, Inc., a significant 10% shareholder in Solidion Technology Inc. (NASDAQ:STI), completed a divestment of 175,000 shares on June 4, 2026, totaling $3,691,205. The transaction occurred as Solidion advances its lithium metal battery portfolio with new patent protections and secures bridge financing from its largest shareholder, M…
Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…
James H. Litinsky, Chairman and CEO of MP Materials Corp. (MP), recently sold 185,167 shares of the company's common stock on June 3, 2026, generating approximately $12.8 million in proceeds. The sales were executed through a weighted average price range of $68.65 to $71.31 per share. Despite the executive's significant divestment, MP Materials rec…
Apogee Therapeutics, Inc. (NASDAQ: APGE) reported that Chief Medical Officer Carl Dambkowski sold 5,500 shares of common stock on June 3, 2026, for a total of $432,904. The transaction was executed at $78.71 per share and followed the exercise of options for 4,125 shares at $22.86 each. The sale was conducted under a Rule 10b5-1 trading plan adopte…
Northeast Community Bancorp (NECB) is a small-cap community bank trading below book and at a single-digit P/E after a solid Q1 that showed continued deposit inflows, disciplined credit and a growing construction loan pipeline. With strategic deposit restructuring lowering funding costs and a sizeable unfunded commitments backlog, NECB looks positio…
Blake Russell, Executive Vice President of Operations at Nexstar Media Group, Inc. (NASDAQ: NXST), executed a transaction involving the sale of 319 shares of the company's common stock. The sale, totaling $58,190, was necessitated by tax withholding requirements associated with the vesting of Restricted Stock Units (RSUs). This event coincides with…
Brett Jenkins, Executive Vice President and Chief Technology & Digital Officer at Nexstar Media Group, Inc. (NASDAQ: NXST), executed a sale of 397 shares of the company's common stock on June 4, 2026. The transaction, valued at approximately $72,418, was conducted to satisfy tax withholding requirements associated with the vesting of restricted sto…
Guardant Health Inc. (NASDAQ: GH) board member Steve Krognes executed a significant divestment of company shares on June 4, 2026, totaling $1,231,521. The transaction involved the sale of 9,294 shares of common stock, executed at prices ranging from $132.50 to $132.71, with a weighted average sale price of $132.5072. Following this transaction, Kro…
Dana Zimmer, President of Distribution & Strategy at Nexstar Media Group, Inc. (NASDAQ:NXST), sold 433 shares of the company's common stock on June 4, 2026. The transaction was valued at $78,985, executed at an average price of $182.4153 per share. The sale was specifically initiated to cover tax withholding obligations linked to the vesting of 938…
Entities linked to Brian N. Sheth, a director and significant shareholder of Blend Labs, Inc. (BLND), have acquired shares totaling $421,334 through Haveli Brooks Aggregator, L.P. The transactions occurred as the stock experienced a recent decline, trading at a discount to its fair value. This insider activity follows the company's mixed first-quar…
Andrew Alford, President of Broadcasting at Nexstar Media Group Inc. (NASDAQ:NXST), executed a sale of company shares on June 4, 2026, totaling $67,128. The transaction involved the disposition of 368 shares at a price of $182.4153 per share. According to Securities and Exchange Commission (SEC) filings, the sale was conducted to cover tax withhold…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Strategy Officer Brian M. Venturo executed a series of stock transactions on June 3, 2026, resulting in the liquidation of approximately $13.05 million in company equity. The sale encompassed both directly held Class A Common Stock and shares converted from Class B Common Stock via West Clay Capital LLC, an enti…
MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…
Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…
Kailera Therapeutics and Hengrui Pharma announced encouraging clinical results for ribupatide, a GLP-1/GIP dual agonist, in both oral and injectable forms for obesity treatment. Phase 2 data from Hengrui showed up to 12.1% mean weight loss with the oral pill over 26 weeks with favorable tolerability. Kailera's Phase 1 trial of the injection demonst…
Brian M. Venturo, CoreWeave's Chief Strategy Officer and director, executed a sale of 15,385 Class A Common Stock shares on June 3, 2026, generating $1,730,905. The transaction, facilitated by the Venturo Family GST Exempt Trust under a Rule 10b5-1 plan adopted in late 2025, includes the conversion of equivalent Class B shares. Following this activ…
